$RLFTF Relief Therapeutics Hldg AG (OTC: RLFTF) Ga
Post# of 653
"The clinical trial will continue to enroll patients through the anticipated early Q1 2021 announcement of top line data in order to amass as large a safety database as possible.
To date, no drug-related Serious Adverse Event has been reported in any of the ongoing studies of RLF-100, which is consistent with the absence of toxicity seen in extensive nonclinical safety testing and prior human studies."
https://durangodowntown.com/events/relief-the...ata-looms/